Baxalta Innovations GmbH
5 products tracked · names used in filings: Baxalta Innovations GmbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Veyvondi vonicog alfa | Authorised | 2018-08-31 |
| 🇪🇺 | Adynovi rurioctocog alfa pegol | Authorised | 2018-01-08 |
| 🇪🇺 | Obizur susoctocog alfa | Authorised | 2015-11-11 |
| 🇪🇺 | Rixubis nonacog gamma | Authorised | 2014-12-19 |
| 🇪🇺 | HyQvia human normal immunoglobulin | Authorised | 2013-05-16 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.